Back to top

cannabis: Archive

Zacks Equity Research

Do Options Traders Know Something About Aurora Cannabis Stock We Don't?

Investors need to pay close attention to ACB stock based on the movements in the options market lately.

ACBPositive Net Change

Zacks Equity Research

GRWG Inks Distribution Agreement With V1 Solutions to Expand Globally

GrowGeneration signs V1 Solutions to drive EU distribution and enters Costa Rica, entering deeper into global cannabis markets.

AGIPositive Net Change SSRMPositive Net Change HWKNNegative Net Change GRWGNegative Net Change

Zacks Equity Research

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook

Jazz reports dismal first-quarter results. The company revises its 2025 EPS guidance to account for the recently completed Chimerix acquisition.

JAZZPositive Net Change PBYINegative Net Change NTLANegative Net Change

Zacks Equity Research

IIPR's Q1 Earnings Coming Up: Key Factors to Impact the Stock

IIPR's Q1 2025 results may be impacted by property repossessions/sales, rent deferrals and partial tenant payments.

IIPRNegative Net Change LAMRNegative Net Change EPRNegative Net Change

Sundeep Ganoria

Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings

Investors will likely focus on the sales performance of Jazz Pharmaceuticals' key neuroscience drugs, Xywav and Rylaze, when it reports Q1 results next week.

JAZZPositive Net Change AMRXPositive Net Change

Sundeep Ganoria

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Both JAZZ and HRMY expect sales from neuroscience products to grow in 2025.

JAZZPositive Net Change HRMYNegative Net Change

Sundeep Ganoria

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

We advise investors to use the price dip in JAZZ stock as a buying opportunity despite the dynamic shifts in the regulatory landscape.

JAZZPositive Net Change EBSNegative Net Change

Urmimala Biswas

Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.

CGCPositive Net Change ACBPositive Net Change OGINegative Net Change

Zacks Equity Research

IIPR's Q4 Earnings Coming Up: Key Factors to Impact the Stock

Innovative Industrial's Q4 performance is likely to have been affected by a decline in contractual rent and property management fees and elevated expenses.

RHPNegative Net Change IIPRNegative Net Change PKNegative Net Change

Moumita C. Chattopadhyay

Is IIPR Stock a Buy, Hold or Sell After Its 49% Plunge in 3 Months?

With a volatile cannabis market and tenant risks, is IIPR's high yield sustainable, or will challenges overshadow its growth?

PLDNegative Net Change TRNONegative Net Change IIPRNegative Net Change

Zacks Equity Research

GrowGeneration Earnings Miss Estimates in Q3, Revenues Dip Y/Y

GRWG expects revenues between $190 million and $195 million for 2024.

BGNegative Net Change RKDANegative Net Change GRWGNegative Net Change WFGPositive Net Change

Zacks Equity Research

Pre-Markets Soar after Trump Wins U.S. Presidential Election

Pre-Markets Soar after Trump Wins U.S. Presidential Election

QCOMPositive Net Change TMPositive Net Change GILDPositive Net Change TSLANegative Net Change TRIPNegative Net Change ACBPositive Net Change COINNegative Net Change ARKBNegative Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q2 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q2 performance, though high expenses might have played a spoilsport.

SPGNegative Net Change APLENegative Net Change IIPRNegative Net Change

Moumi Mondal

Should You Buy Canopy Growth (CGC) Ahead of Q4 Earnings?

Canopy Growth's (CGC) rightsized cannabis-focused business is a major foundation for growth.

INGNNegative Net Change HQYNegative Net Change CGCPositive Net Change HIMSNegative Net Change

Madhurima Das

4 Agriculture - Products Stocks to Watch in a Thriving Industry

The Agriculture - Products industry is set to gain from solid demand. Stocks like WestFraser (WFG), CalMaine Foods (CALM), Andersons (ANDE) and Hydrofarm (HYFM) are poised to ride on this positive trend.

WFGPositive Net Change ANDENegative Net Change CALMNegative Net Change HYFMNo Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q1 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q1 performance, though high expenses might have played a spoilsport.

MPWNegative Net Change IIPRNegative Net Change PKSTPositive Net Change

Zacks Equity Research

New Strong Buy Stocks for April 2nd

CXDO, HITI, SIGA, CPG and CTKB have been added to the Zacks Rank #1 (Strong Buy) List on April 2, 2023.

SIGANegative Net Change CPGPositive Net Change CXDONegative Net Change HITINegative Net Change CTKBPositive Net Change

Zacks Equity Research

GrowGeneration (GRWG) Q4 Earnings Miss, Revenues Dip Y/Y

GrowGeneration's (GRWG) 2023 top line falls y/y despite improvements in the product mix.

ECLNegative Net Change CRSPositive Net Change HWKNNegative Net Change GRWGNegative Net Change

Zacks Equity Research

Jazz (JAZZ) Q3 Earnings Lag, Revenues in Line With Estimates

Jazz's (JAZZ) fourth-quarter earnings miss estimates while sales meet the mark. Shares drop 1.5% post the announcement.

JAZZPositive Net Change ACETNegative Net Change PBYINegative Net Change ADMAPositive Net Change

Tracey Ryniec

Pot Stocks: Values or Traps?

Pot stocks used to be hot but many have plunged over the last 2 years. Are there deals?

STZNegative Net Change JAZZPositive Net Change IIPRNegative Net Change CGCPositive Net Change TLRYNegative Net Change

Zacks Equity Research

GrowGeneration (GRWG) Q3 Earnings Miss, Revenues Dip Y/Y

GrowGeneration (GRWG) witnesses year-over-year decline in retail revenues, e-commerce revenues and non-retail operations in Q3.

ANDENegative Net Change CRSPositive Net Change USAPPositive Net Change GRWGNegative Net Change

Zacks Equity Research

Jazz (JAZZ) Lags Q3 Earnings, Beats Sales, Raises '23 View

Jazz (JAZZ) reports mixed results in third-quarter 2023. However, shares rose 2.5% post the announcement, likely on the back of raised guidance for 2023.

JAZZPositive Net Change BHVNNegative Net Change CDMOPositive Net Change APLSPositive Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q3 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q3 performance, though high expenses might have played a spoilsport.

VTRPositive Net Change DEANegative Net Change IIPRNegative Net Change

Neena Mishra

Cannabis Stocks & ETFs: Can the Recent Surge Continue?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

TLRYNegative Net Change CNBSPositive Net Change GTBIFPositive Net Change CURLFPositive Net Change

Brian Bolan

Cannabis Stocks Are Moving Higher

A looking into what is driving the recent spike in cannabis stocks.

TLRYNegative Net Change YOLOPositive Net Change